Our comprehensive Metabolite Standards Library enhances the speed, quality, and extent of metabolite identification.
Our comprehensive Metabolite Standards Library enhances the speed, quality, and extent of metabolite identification.
See how these capabilities enhance the speed, quality & extent of metabolite identification for accelerated insights.
How next-gen proteomics methods for protein biomarker discovery are opening exciting new avenues in CDx development.
Using mass spectrometry to deliver quantitative measures for specific proteins in plasma, cells, and tissue.
Now available on demand! See the scientific innovations expanding the druggable space and enabling discovery of novel targets.
Talking multiomics data and how it can take pharmacogenomics to the next level such as in predicting patient response.
Featuring Sapient’s platform as an omics technology advancing the discovery & implementation of dynamic biomarkers.
How multi-omics biomarker strategies are helping to realize the incredible therapeutic potential in these pipelines today.
Dr. Usuka will lead global business strategy for commercial collaborations, strategic partnerships & client service innovations.
Using metabolite biomarkers to speed GLP-1 agonist time-to-market & drive competitive advantages via novel insights.
10421 Wateridge Circle, Suite 100
San Diego, CA 92121
discover@sapient.bio
858.290.7010
© 2024 Sapient Bioanalytics, LLC. All rights reserved.
SAPIENT, the SAPIENT Logo, ACCELERATE HUMAN DISCOVERY, and SPECIFICITY AT SCALE are trademarks of Sapient Bioanalytics, LLC
